The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells

PURPOSE: Glioblastoma multiforme (GBM) is resistant to current cytotoxic therapies, in part because of enhanced DNA repair. Activation of the receptor tyrosine kinase c-Met has been shown to protect cancer cells from DNA damage. We hypothesized that inhibiting c-Met would decrease this protection an...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh, James W, Mahadevan, Daruka, Ellsworth, Ron, Cooke, Laurence, Bearss, David, Stea, Baldassarre
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806296/
https://www.ncbi.nlm.nih.gov/pubmed/20028557
http://dx.doi.org/10.1186/1748-717X-4-69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806296/
https://www.ncbi.nlm.nih.gov/pubmed/20028557
http://dx.doi.org/10.1186/1748-717X-4-69

Ejemplares similares